May 29 |
Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
|
May 8 |
Enanta Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
May 7 |
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2024 Earnings Call Transcript
|
May 7 |
Q2 2024 Enanta Pharmaceuticals Inc Earnings Call
|
May 7 |
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
|
May 7 |
Enanta Pharmaceuticals Inc (ENTA) (Q2 2024) Earnings Call Transcript Highlights: Navigating ...
|
May 7 |
Enanta Pharmaceuticals, Inc. (ENTA) Q2 2024 Earnings Call Transcript
|
May 6 |
Enanta Pharmaceuticals Reports Fiscal Q2 Results: A Closer Look Against Analyst Expectations
|
May 6 |
Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Tops Revenue Estimates
|
May 6 |
Enanta Pharma GAAP EPS of -$1.47 misses by $0.17, revenue of $17.05M beats by $0.84M
|